Better prevention and treatment of cancer for people living with HIV
Consortium for Advancing Management and Prevention of Cancer in People with HIV
This program tries new ways to prevent, find, and treat cancers that affect people living with HIV in the U.S. and around the world.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11406616 on NIH RePORTER |
What this research studies
If you live with HIV, you may be able to join clinical trials that explore new prevention methods, screening approaches, and treatments for cancers such as anal cancer. The consortium runs trials at a network of clinics in the U.S., sub-Saharan Africa, and Latin America and links those trials to laboratory research to understand how cancers develop in people with HIV. Community advocates and a Global Community Advisory Board help shape the research so studies address real patient needs. The program has enrolled thousands of participants and aims to translate lab findings into better care.
Who could benefit from this research
Good fit: Ideal candidates are people living with HIV who have or are at risk for cancers studied by the consortium and who can attend one of the participating clinic sites.
Not a fit: People who do not have HIV, whose cancer type is not included in current trials, or who cannot travel to participating sites may not benefit directly from this program.
Why it matters
Potential benefit: If successful, this program could lower cancer rates, improve treatment options, and reduce illness and deaths among people living with HIV.
How similar studies have performed: Yes — the AMC has run dozens of interventional trials enrolling thousands of participants and produced results that have changed clinical guidelines in the U.S. and low- and middle-income countries.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sparano, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.